ALCOHOLIC LIVER DISEASE: ISSUES OF ETIOLOGY AND THE IMPACT OF RISK FACTORS (LITERATURE REVIEW)
https://doi.org/10.57256/2949-0715-2023-2-20-29
Abstract
Alcohol consumption is one of the main causes leading to chronic liver disease. Alcoholic liver disease is a set of cascading events, consisting first of alcoholic hepatic steatosis and then mainly through alcoholic steatohepatitis, leading to cirrhosis and hepatocellular carcinoma. This review considers chronic alcohol intoxication as the main factor in the development of liver disease. Modern data on the prevalence of forms of alcoholic liver damage in Russia and in the world are presented. The role of the consumed dose of ethanol, the nature of the alcoholic beverage, as well as the pattern of alcohol consumption in the formation of liver damage is assessed, predisposing factors are presented. The leading risk factors for alcoholic liver damage are: female gender, hereditary predisposition (ethnicity), trophological status (underweight or obesity), taking certain hepatotoxic drugs, the amount and duration of alcohol consumption and the type of alcohol consumed, smoking. The presence of concomitant viral hepatitis, environmental toxico-ecological influence and prenatal intoxication also predispose to alcoholic liver damage. The article provides a detailed assessment of the role of the presented risk factors in the development of alcoholic liver damage. However, it is not possible to identify the dominant risk factor for alcoholic liver damage, since the development of liver pathology directly depends not only on the amount of alcohol consumed, but also on the individual combination of predisposing factors. Understanding the etiology of the disease and the contribution of modifiable risk factors to its development will allow the development of effective strategies aimed at reducing the incidence and mortality from liver diseases.
About the Authors
Daria A. Stepanenko
Irkutsk State Medical University
Russian Federation
Russian Federation
Tatyana V. Goma
Irkutsk State Medical University
Russian Federation
Russian Federation
Natalia M. Kozlova
Irkutsk State Medical University
Russian Federation
Russian Federation
References
1. Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20(1):37-49. DOI:10.1038/s41575-022-00688-6
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572-1585. DOI:10.1053/j.gastro.2011.09.002
3. Teschke R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines. 2018;6(4):106. DOI:10.3390/biomedicines6040106
4. Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718-735. DOI:10.1016/j.jhep.2018.05.011
5. Sheron N, Chilcott F, Matthews L, Challoner B, Thomas M. Impact of minimum price per unit of alcohol on patients with liver disease in the UK. Clin Med (Lond). 2014;14(4):396-403. DOI:10.7861/clinmedicine.14-4-396
6. Клинические рекомендации. Проект. Алкогольная болезнь печени (АБП) у взрослых. [Clinical guidelines. Project. Alcoholic liver disease (ALD) in adults (in Russian)]. https://cr.minzdrav.gov.ru/recomend/711_1 [дата доступа: 10.05.2023].
7. Маев И.В., Абдурахманов Д.Т., Андреев Д.Н., Дичева Д.Т. Алкогольная болезнь печени: современное состояние проблемы. Терапевтический архив. 2014;86(4):108-16 [Maev IV, Abdurakhmanov DT, Andreev DN, Dicheva DT. Alcoholic liver disease: State-of-the-art. Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(4):108-16 (in Russian)].
8. Aslam A, Kwo PY. Epidemiology and Disease Burden of Alcohol Associated Liver Disease. J Clin Exp Hepatol. 2023;13(1):88-102. DOI:10.1016/j.jceh.2022.09.001
9. Zaridze D, Brennan P, Boreham J, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009;373(9682):2201-2214. DOI:10.1016/S0140-6736(09)61034-5
10. WHO. Alcohol. Available at: https://www.who.int/news-room/fact-sheets/detail/alcohol [accessed: 10.05.2023].
11. Ritchie H, Roser M. Alcohol Consumption. Our World in Data Published online at OurWorldInData.org. 2018. Available at: https://ourworldindata.org/alcohol-consumption. Accessed: 10.01.2023.
12. Замятнина Е.С. Структура непосредственно обусловленной алкоголем смертности в России в 2011-2021 гг. Демографическое обозрение. 2022; 9(2):102-118 [ Zamyatnina E. The structure of directly related alcohol mortality In Russia from 2011 to 2021. Demographic Review. 2022;9(2):102-118 (In Russian)]. DOI:10.17323/demreview.v9i2.16208 :.
13. White AM, Castle IP, Powell PA, Hingson RW, Koob GF. Alcohol-Related Deaths During the COVID-19 Pandemic. JAMA. 2022;327(17):1704-1706. DOI:10.1001/jama.2022.4308
14. Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today?. J Intern Med. 2015;278(3):238-250. DOI:10.1111/joim.12390
15. Лазебник Л.Б., Голованова Е.В., Тарасова Л.В. и др. Алкогольная болезнь печени (АБП) у взрослых. Экспериментальная и клиническая гастроэнтерология. 2020;174(2):4-28 [Lazebnik L.B., Golovanova E.V., Tarasova L.V. et al. Adult Alcoholic Liver Disease. Experimental and Clinical Gastroenterology. 2020;174(2):4-28 (In Russian)]. DOI: 10.31146/1682-8658-ecg-174-2-4-28
16. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181. doi:10.1016/j.jhep.2018.03.018
17. Askgaard G, Leon DA, Kjaer MS, Deleuran T, Gerds TA, Tolstrup JS. Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study. Hepatology. 2017;65(3):929-937. DOI:10.1002/hep.28943
18. Hagström H. Alcohol, smoking and the liver disease patient. Best Pract Res Clin Gastroenterol. 2017;31(5):537-543. DOI:10.1016/j.bpg.2017.09.003
19. Калинин А.В. Вопросы патогенеза, клиники и лечения алкогольной болезни печени. Клинич. перспективы гастроэнтерол. гепатол. 2001;(4):8-14 [Kalinin A.V. Issues of pathogenesis, clinic and treatment of alcoholic liver disease. Clinical prospects for gastroenterol. hepatol. 2001;(4):8-14 (In Russian)].
20. Rehm J, Crépault JF, Wettlaufer A. et al. What is the best indicator of the harmful use of alcohol? A narrative review. Drug Alcohol Rev. 2020;39(6):624-631. DOI:10.1111/dar.13053
21. Szabo G, Wands JR, Eken A, et al. Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res. 2010;34(10):1675-1686. DOI:10.1111/j.1530-0277.2010.01255.x
22. Wagnerberger S, Fiederlein L, Kanuri G, et al. Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice. Alcohol Alcohol. 2013;48(6):648-656. DOI:10.1093/alcalc/agt138
23. Ding WX, Yang L. Alcohol and drug-induced liver injury: Metabolism, mechanisms, pathogenesis and potential therapies. Liver Res. 2019;3(3-4):129-131. DOI:10.1016/j.livres.2019.11.006
24. WHO. Harmful use of alcohol kills more than 3 million people each year, most of them men. https://www.who.int/ru/news/item/21-09-2018-harmful-use-of-alcohol-kills-more-than-3-million-people-each-year--most-of-them-men [accessed: 10.05.2023].
25. Никифоров ИА, Чернобровкина ТВ, Жовнерчук ЕВ и др. Поражение печени при алкоголизме (обзор литературы). Профилактическая медицина. 2014;17(3):55-61. [Nikiforov IA, Chernobrovkina TV, Zhovnerchuk EV. et al. Liver damage in alcoholism (review). Profilakticheskaya meditsina. 2014;17(3):55-61. (In Russian)].
26. Erol A, Karpyak VM. Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. Drug Alcohol Depend. 2015;156:1-13. DOI:10.1016/j.drugalcdep.2015.08.023
27. Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002;3(6):561-597. DOI:10.2174/1389200023337054
28. Chen CH, Ferreira JCB, Joshi AU, et al. Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicity. EBioMedicine. 2020;55:102753. DOI:10.1016/j.ebiom.2020.102753
29. Li D, Zhao H, Gelernter J. Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians. Hum Genet. 2012;131(5):725-737. DOI:10.1007/s00439-011-1116-4
30. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572-1585. DOI:10.1053/j.gastro.2011.09.002
31. Effenberger M, Widjaja AA, Grabherr F, et al. Interleukin-11 drives human and mouse alcohol-related liver disease. Gut. 2023;72(1):168-179. DOI:10.1136/gutjnl-2021-326076
32. Иванов А.С., Гармаш И.В., Аришева О.С. и др. Значение иммуновоспалительных и генетических факторов в развитии алкогольного фиброза печени. Клиническая фармакология и терапия. 2018;27(5):30-36 [Ivanov AS, Garmasch IV, Arisheva OS. et al. Immune-inflammatory and genetic factors in the development of alcoholic liver fibrosis. Clin Pharmacol Ther 2018;27(5):30-36 (In Russian)]. DOI 10.32756/0869-5490-2018-5-30-35
33. Ma HY, Yamamoto G, Xu J, et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J Hepatol. 2020;72(5):946-959. DOI:10.1016/j.jhep.2019.12.016
34. Im GY. Emerging Biomarkers in Alcohol-associated Hepatitis. J Clin Exp Hepatol. 2023;13(1):103-115. DOI:10.1016/j.jceh.2022.07.246
35. Никифоров И.А. Бурыгина Л.А., Белова М.Ю., Костюк Г.П. Хроническая алкогольная интоксикация и коморбидные расстройства кишечника (обзор литературы). Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2021;(5):145-150 [Nikiforov A., Burygina L., Belova M., Kostyuk G. Chronic alcohol intoxication and comorbid bowel disorders (literature review). Modern Science: Actual Problems of Theory and Practice. Series: Natural and technical sciences. 2021;(5):145-150 (In Russian)]. DOI:10.37882/2223–2966.2021.05–2.19
36. Tadokoro T, Morishita A, Himoto T, Masaki T. Nutritional Support for Alcoholic Liver Disease. Nutrients. 2023;15(6):1360. DOI:10.3390/nu15061360
37. Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017;11(2):173-188. DOI:10.5009/gnl16477
38. Minato T, Tsutsumi M, Tsuchishima M, et al. Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis. Mol Med. 2014;20(1):490-502. DOI:10.2119/molmed.2014.00048
39. Taniai M, Hashimoto E, Tokushige K, et al. Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease. Hepatol Res. 2012;42(4):359-367. DOI:10.1111/j.1872-034X.2011.00935.x
40. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010;340:c1240. DOI:10.1136/bmj.c1240
41. Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123-2132. DOI:10.2337/dc09-0227
42. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015-1035.DOI:10.1016/S0140-6736(18)31310-2
43. Авцын А.П., Жаворонков А.А., Риш М.А. и др. Микроэлементозы человека. М.:Медицина;1991 [Avtsyn A.P., Zhavoronkov A.A., Rish M.A. and others. Human microelementoses. M.: Medicine; 1991 (In Russian)].
44. Скальный А.В., Курчашова С.Ю., Вятчанина Е.С. Дисбаланс цинка и других микроэлементов при алкоголизме и алкогольной эмбриофетопатии в России. Наркология, 2008;(5): 26-33 [Skalny A.V., Kurchashova S.Yu., Vyatchanina E.S. Imbalance of zinc and other trace elements in alcoholism and alcoholic embryopathy in Russia. Narcology, 2008;(5): 26-33 (In Russian)].
45. Desbrow B, Cecchin D, Jones A, Grant G, Irwin C, Leveritt M. Manipulations to the Alcohol and Sodium Content of Beer for Postexercise Rehydration. Int J Sport Nutr Exerc Metab. 2015;25(3):262-270. DOI:10.1123/ijsnem.2014-0064
46. Dopico AM, Bukiya AN, Bettinger JC. Voltage-Sensitive Potassium Channels of the BK Type and Their Coding Genes Are Alcohol Targets in Neurons. Handb Exp Pharmacol. 2018;248:281-309. DOI:10.1007/164_2017_78
47. Iwakiri Y, Nathanson MH. Alcohol and calcium make a potent cocktail. J Physiol. 2017;595(10):3109-3110. doi:10.1113/JP274133
48. Grochowski C, Blicharska E, Baj J, et al. Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review. Molecules. 2019;24(7):1361. DOI:10.3390/molecules24071361
49. Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016;43(5):562-574. DOI:10.1111/apt.13523
50. Hou C, Zeng Y, Chen W, et al. Medical conditions associated with coffee consumption: Disease-trajectory and comorbidity network analyses of a prospective cohort study in UK Biobank. Am J Clin Nutr. 2022;116(3):730-740. DOI:10.1093/ajcn/nqac148
51. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry. 2008;65(6):674-682. DOI:10.1001/archpsyc.65.6.674
52. Билалова А.Р., Макашова В.В. Клинико-лабораторная характеристика хронических гепатитов и циррозов печени различной. Архивъ внутренней медицины. 2015;(2):8-14 [Bilalova A.R., Makashova V.V. Clinical and laboratory characteristics of chronic hepatitis and various cirrhosis of the liver. The Russian Archives of Internal Medicine. 2015;(2):8-14 (In Russian)]. DOI:10.20514/2226-6704-2015-0-2-8-14
53. Hallager S, Ladelund S, Christensen PB, et al. Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response. Clin Epidemiol. 2017;9:501-516. DOI:10.2147/CLEP.S132072
54. Younossi Z, Henry L. Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens. Aliment Pharmacol Ther. 2015;41(6):497-520. DOI:10.1111/apt.13090
55. Marjot T, Moon AM, Cook JA, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021;74(3):567-577. doi:10.1016/j.jhep.2020.09.024
56. Ситникова Е.Ю., Ильченко Л.Ю., Федоров И.Г., Никитин И.Г. Хронические заболевания печени и сovid-19: база данных многопрофильного стационара. Архивъ внутренней медицины. 2023;13(1):57-64 [Sitnikova E.Yu., Ilchenko L.Yu., Fedorov I.G., Nikitin I.G. Chronic Liver Diseases and COVID-19: Database of General Hospital. The Russian Archives of Internal Medicine. 2023;13(1):57-64 (In Russian)]. DOI:10.20514/2226-6704-2023-13-1-57-64
57. Szabo G, Saha B. Alcohol's Effect on Host Defense. Alcohol Res. 2015;37(2):159-170
58. Чернобровкина Т.В., Артемчук А.Ф., Сосин И.К. и др. Проблема коморбидности и современные формы алкогольной болезни (клинико-патогенетический аспект). Наркология. 2006;(12):47-70 [Chernobrovkina T.V., Artemchuk A.F., Sosin I.K. et al. The problem of comorbidity and modern forms of alcoholic disease (clinical and pathogenetic aspect). Narcology. 2006;(12):47-70 (In Russian)].
59. Zhang R, Tang Z, Xu W, et al. Risk factors and protective factors for alcohol-related liver disease: A systematic review and meta-analysis. Alcohol Clin Exp Res. 2022;46(12):2128-2136. DOI:10.1111/acer.14951
60. Dam MK, Flensborg-Madsen T, Eliasen M, Becker U, Tolstrup JS. Smoking and risk of liver cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2013;48(5):585-591. DOI:10.3109/00365521.2013.777469
61. Высокогорский В.Е., Курч Н.М. Метаболический импринтинг пренатальной алкогольной интоксикации. 2014. Сибирский научный медицинский журнал (Бюллетень СО РАМН). 2014;34(1):5-9 [Vysokogorsky V.E., Kurch N.M. Metabolic imprinting of prenatal alcohol intoxication. 2014. Siberian Scientific Medical Journal (Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences). 2014;34(1):5-9 (In Russian)].
62. Liu Q, Gao F, Liu X, et al. Prenatal alcohol exposure and offspring liver dysfunction: a systematic review and meta-analysis. Arch Gynecol Obstet. 2016;294(2):225-231. DOI:10.1007/s00404-016-4109-7
63. Asiedu B, Nyakudya TT, Lembede BW, Chivandi E. Early-life exposure to alcohol and the risk of alcohol-induced liver disease in adulthood. Birth Defects Res. 2021;113(6):451-468. DOI:10.1002/bdr2.1881
Review
For citations:
Stepanenko D.A., Goma T.V., Kozlova N.M. ALCOHOLIC LIVER DISEASE: ISSUES OF ETIOLOGY AND THE IMPACT OF RISK FACTORS (LITERATURE REVIEW). Baikal Medical Journal. 2023;2(2):20-29. (In Russ.) https://doi.org/10.57256/2949-0715-2023-2-20-29
Views:
1744
